These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1000 related items for PubMed ID: 15942051

  • 1. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J, Konno A, Hashimoto Y, Kon Y.
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [Abstract] [Full Text] [Related]

  • 5. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D, Yang H, Kong X, Wang K, Mao X, Yan X, Wang Y, Liu S, Zhang X, Li J, Chen L, Wu J, Wei M, Yang J, Guan Y.
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [Abstract] [Full Text] [Related]

  • 6. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF, Milena FJ, Mora C, León C, García J.
    Am J Nephrol; 2006 Feb; 26(6):562-70. PubMed ID: 17167242
    [Abstract] [Full Text] [Related]

  • 7. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat.
    Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, Burns KD.
    Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066
    [Abstract] [Full Text] [Related]

  • 8. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS.
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [Abstract] [Full Text] [Related]

  • 9. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK, Gilbert RE.
    Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
    [Abstract] [Full Text] [Related]

  • 10. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 11. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.
    Acta Histochem; 2002 May 20; 104(2):123-30. PubMed ID: 12086332
    [Abstract] [Full Text] [Related]

  • 12. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.
    Diabetes; 2008 Jun 20; 57(6):1712-22. PubMed ID: 18285555
    [Abstract] [Full Text] [Related]

  • 13. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 14. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.
    Horm Metab Res; 2004 Jul 28; 36(7):458-64. PubMed ID: 15305228
    [Abstract] [Full Text] [Related]

  • 15. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ, Buck D, Cox AJ, Zhang Y, Gilbert RE.
    Am J Physiol Renal Physiol; 2007 Aug 28; 293(2):F565-74. PubMed ID: 17522264
    [Abstract] [Full Text] [Related]

  • 16. ACE and ACE2 activity in diabetic mice.
    Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D.
    Diabetes; 2006 Jul 28; 55(7):2132-9. PubMed ID: 16804085
    [Abstract] [Full Text] [Related]

  • 17. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2010 Nov 28; 299(5):F1203-11. PubMed ID: 20719975
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M.
    Nephrol Dial Transplant; 2009 Jun 28; 24(6):1744-52. PubMed ID: 19103735
    [Abstract] [Full Text] [Related]

  • 19. Identification of angiotensin converting enzyme 2 in the rodent retina.
    Tikellis C, Johnston CI, Forbes JM, Burns WC, Thomas MC, Lew RA, Yarski M, Smith AI, Cooper ME.
    Curr Eye Res; 2004 Dec 28; 29(6):419-27. PubMed ID: 15764086
    [Abstract] [Full Text] [Related]

  • 20. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
    Liu DX, Liu XM, Su Y, Zhang XJ.
    Acta Histochem; 2011 Sep 28; 113(5):527-33. PubMed ID: 20598359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.